E. Ohman J:Or Asset Management Ab Rhythm Pharmaceuticals, Inc. Transaction History
E. Ohman J:Or Asset Management Ab
- $4.25 Trillion
- Q3 2025
A detailed history of E. Ohman J:Or Asset Management Ab transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, E. Ohman J:Or Asset Management Ab holds 8,213 shares of RYTM stock, worth $880,022. This represents 0.02% of its overall portfolio holdings.
Number of Shares
8,213
Previous 8,213
-0.0%
Holding current value
$880,022
Previous $519 Million
59.82%
% of portfolio
0.02%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding RYTM
# of Institutions
250Shares Held
63.9MCall Options Held
210KPut Options Held
575K-
Black Rock Inc. New York, NY6.74MShares$722 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY5.6MShares$601 Million3.59% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.56MShares$596 Million7.68% of portfolio
-
Primecap Management CO Pasadena, CA4.88MShares$523 Million0.25% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.59MShares$385 Million0.0% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $5.97B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...